Skip to main content
Log in

Valganciclovir for CMV prevention better option, cost saving

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Luan F, et al. Cost Effective Prevention of CMV Infection and Its Long-Term Consequence. American Transplant Congress - 13th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation : abstr. 505, 18 May 2013.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valganciclovir for CMV prevention better option, cost saving. PharmacoEcon Outcomes News 679, 7 (2013). https://doi.org/10.1007/s40274-013-0438-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0438-y

Navigation